Moderna is up 109% in 2026. Jim Cramer just called it 'finally investable again.' Is the stock a no-brainer buy on its recent pullback?

A fresh era of earnings growth may be on the horizon.

Jim Cramer turns bullish on Moderna stock after years of doubt

The "Mad Money" host revisits a stock he spent years dismissing.

Moderna's now got a lot going for it, says Jim Cramer

CNBC's Jim Cramer talks about his take on Moderna's stock performance and business outlook.

Jim Cramer says this former Covid market darling is finally investable again

CNBC's Jim Cramer said Moderna's expanding pipeline in treatments for cancer and other diseases provides a compelling long-term investment thesis.
Insider Monkey

Jim Cramer on Moderna: “Even Though the Stock’s on the Mend, There Are Many Pharma and Biotech Names That I Like Better”

Moderna, Inc. (NASDAQ:MRNA) is one of the noteworthy S&P 500 stocks Jim Cramer highlighted. Cramer highlighted that the company is likely to remain unprofitable for “years to come,” as he stated: Next ...
Insider Monkey

Jim Cramer on Moderna: “One of the Hottest Stocks in the Market This Year”

Moderna, Inc. (NASDAQ:MRNA) is one of the stocks in focus on Jim Cramer’s game plan. Cramer finished his game plan with the stock, as he commented: Finally, Friday, we’re going to hear from Moderna, ...
AOL

Jim Cramer turns bullish on health care stock after years of doubt

Moderna gains momentum as unanimous FDA advisory support for its flu vaccine boosts approval prospects and reinforces long-term growth optimism.NurPhoto&solGetty Images For most of the past three ...